Stock BOUL BOULE DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Boule Diagnostics AB

Equities

BOUL

SE0011231158

Market Closed - Nasdaq Stockholm
Other stock markets
 11:15:05 2024-05-21 am EDT 		5-day change 1st Jan Change
10.2 SEK +2.00% Intraday chart for Boule Diagnostics AB +2.20% -9.09%
May. 08 Boule Diagnostics AB Appoints Rikke Rytter as Director CI
May. 07 Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bulletin from the Annual General Meeting May 8, 2024 in Boule Diagnostics AB
AQ
Boule Diagnostics AB Appoints Rikke Rytter as Director
CI
Transcript : Boule Diagnostics AB, Q1 2024 Earnings Call, May 07, 2024
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
Transcript : Boule Diagnostics AB, 2023 Earnings Call, Feb 06, 2024
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Boule Diagnostics AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Boule Diagnostics AB, Q3 2023 Earnings Call, Nov 09, 2023
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Boule Diagnostics AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Transcript : Boule Diagnostics AB, Q1 2023 Earnings Call, May 03, 2023
Boule Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Transcript : Boule Diagnostics AB, 2022 Earnings Call, Feb 02, 2023
Boule Diagnostics : interim report Q4 2022
PU
Boule Diagnostics AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022
CI
Transcript : Boule Diagnostics AB, Q3 2022 Earnings Call, Nov 10, 2022
Boule Diagnostics AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Rights Issue: 1 new share @ 7.7 SEK for 1 existing share
FA
Boule Diagnostics AB announced that it has received funding from Keel Capital Ab
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BOUL Stock
  4. News Boule Diagnostics AB
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW